Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1994 1
1998 1
1999 1
2000 1
2001 1
2003 2
2004 2
2005 1
2007 2
2008 1
2009 8
2010 6
2011 2
2012 7
2013 12
2014 20
2015 17
2016 20
2017 11
2018 20
2019 26
2020 30
2021 26
2022 27
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, Rutakingirwa MK, Ssebambulidde K, Tugume L, Rhein J, Boulware DR, Mwandumba HC, Moyo M, Mzinganjira H, Kanyama C, Hosseinipour MC, Chawinga C, Meintjes G, Schutz C, Comins K, Singh A, Muzoora C, Jjunju S, Nuwagira E, Mosepele M, Leeme T, Siamisang K, Ndhlovu CE, Hlupeni A, Mutata C, van Widenfelt E, Chen T, Wang D, Hope W, Boyer-Chammard T, Loyse A, Molloy SF, Youssouf N, Lortholary O, Lalloo DG, Jaffar S, Harrison TS; Ambition Study Group. Jarvis JN, et al. N Engl J Med. 2022 Mar 24;386(12):1109-1120. doi: 10.1056/NEJMoa2111904. N Engl J Med. 2022. PMID: 35320642 Free PMC article. Clinical Trial.
METHODS: In this phase 3 randomized, controlled, noninferiority trial conducted in five African countries, we assigned HIV-positive adults with cryptococcal meningitis in a 1:1 ratio to receive either a single high dose of liposomal amphotericin B (10 mg per kilogram of bo …
METHODS: In this phase 3 randomized, controlled, noninferiority trial conducted in five African countries, we assigned HIV-positive a …
Nurse-Physician Communication Team Training in Virtual Reality Versus Live Simulations: Randomized Controlled Trial on Team Communication and Teamwork Attitudes.
Liaw SY, Ooi SW, Rusli KDB, Lau TC, Tam WWS, Chua WL. Liaw SY, et al. J Med Internet Res. 2020 Apr 8;22(4):e17279. doi: 10.2196/17279. J Med Internet Res. 2020. PMID: 32267235 Free PMC article. Clinical Trial.
A randomized controlled trial study was conducted with 120 undergraduate medical and nursing students who were randomly assigned to undertake team training using virtual reality or live simulations. ...
A randomized controlled trial study was conducted with 120 undergraduate medical and nursing students who were randomly assigned to u …
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.
Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Hong CHL, et al. Support Care Cancer. 2019 Oct;27(10):3949-3967. doi: 10.1007/s00520-019-04848-4. Epub 2019 Jul 8. Support Care Cancer. 2019. PMID: 31286232
The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. ...
The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added t …
The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial.
Poole AP, Finnis ME, Anstey J, Bellomo R, Bihari S, Biradar V, Doherty S, Eastwood G, Finfer S, French CJ, Heller S, Horowitz M, Kar P, Kruger PS, Maiden MJ, Mårtensson J, McArthur CJ, McGuinness SP, Secombe PJ, Tobin AE, Udy AA, Young PJ, Deane AM; LUCID Study Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG). Poole AP, et al. Am J Respir Crit Care Med. 2022 Oct 1;206(7):874-882. doi: 10.1164/rccm.202202-0329OC. Am J Respir Crit Care Med. 2022. PMID: 35608484 Free article. Clinical Trial.
Measurements and Main Results: By Day 28, at least one episode of hypoglycemia occurred in 10 of 210 (5%) patients assigned the intervention and 38 of 209 (18%) patients assigned the comparator (incident rate ratio, 0.21 [95% confidence interval (CI), 0.09 to 0.49]; …
Measurements and Main Results: By Day 28, at least one episode of hypoglycemia occurred in 10 of 210 (5%) patients assigned the inter …
Effectiveness of a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A randomized controlled trial.
Jiang Y, Ramachandran HJ, Teo JYC, Leong FL, Lim ST, Nguyen HD, Wang W. Jiang Y, et al. J Adv Nurs. 2022 Apr;78(4):1154-1165. doi: 10.1111/jan.15178. Epub 2022 Feb 15. J Adv Nurs. 2022. PMID: 35170786 Clinical Trial.
METHODS: Participants were recruited from June 2018 to September 2020. Eligible participants were assigned to either the intervention or control group randomly. Participants assigned to intervention group received the 6-month NSSMP, while those in the control group …
METHODS: Participants were recruited from June 2018 to September 2020. Eligible participants were assigned to either the intervention …
Effectiveness of a nurse-led temporal self-regulation theory-based program on heart failure self-care: A randomized controlled trial.
Chew HSJ, Sim KLD, Choi KC, Chair SY. Chew HSJ, et al. Int J Nurs Stud. 2021 Mar;115:103872. doi: 10.1016/j.ijnurstu.2021.103872. Epub 2021 Jan 12. Int J Nurs Stud. 2021. PMID: 33516047 Clinical Trial.
SETTINGS & PARTICIPANTS: 144 patients with heart failure were recruited from September 2018 to July 2019 at a tertiary hospital in Singapore. METHODS: Participants were randomly assigned to a self-regulation intervention (n = 72) or usual care group (n = 72). ...
SETTINGS & PARTICIPANTS: 144 patients with heart failure were recruited from September 2018 to July 2019 at a tertiary hospital in Singa …
Neurophysiological and behavioral effects of multisession prefrontal tDCS and concurrent cognitive remediation training in patients with autism spectrum disorder (ASD): A double-blind, randomized controlled fNIRS study.
Han YMY, Chan MMY, Shea CKS, Lai OL, Krishnamurthy K, Cheung MC, Chan AS. Han YMY, et al. Brain Stimul. 2022 Mar-Apr;15(2):414-425. doi: 10.1016/j.brs.2022.02.004. Epub 2022 Feb 15. Brain Stimul. 2022. PMID: 35181532 Free article. Clinical Trial.
OBJECTIVE: This two-armed, double-blind, randomized, sham-controlled trial aimed to investigate the beneficial effects of tDCS combined with concurrent cognitive remediation training on adolescents and young adults with ASD. METHODS: Participants were randomly assigned to …
OBJECTIVE: This two-armed, double-blind, randomized, sham-controlled trial aimed to investigate the beneficial effects of tDCS combined with …
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, de Groot P, Sulman EP, Wistuba II, Chen A, Fleisher M, Heymach JV, Kris MG, Rudin CM, Byers LA. Pietanza MC, et al. J Clin Oncol. 2018 Aug 10;36(23):2386-2394. doi: 10.1200/JCO.2018.77.7672. Epub 2018 Jun 15. J Clin Oncol. 2018. PMID: 29906251 Free PMC article. Clinical Trial.
Patients and Methods A total of 104 patients with recurrent SCLC were randomly assigned 1:1 to oral veliparib or placebo 40 mg twice daily, days 1 to 7, and oral TMZ 150 to 200 mg/m(2)/day, days 1 to 5, of a 28-day cycle until disease progression, unacceptable toxicity, or …
Patients and Methods A total of 104 patients with recurrent SCLC were randomly assigned 1:1 to oral veliparib or placebo 40 mg twice …
Exploring Obscurin and SPEG Kinase Biology.
Fleming JR, Rani A, Kraft J, Zenker S, Börgeson E, Lange S. Fleming JR, et al. J Clin Med. 2021 Mar 2;10(5):984. doi: 10.3390/jcm10050984. J Clin Med. 2021. PMID: 33801198 Free PMC article.
Our homology modeling, mutational analysis and molecular docking demonstrate that kinase 1 in obscurin harbors all key amino acids important for its catalytic function and that actions of this domain result in autophosphorylation of the protein. Our bioinformatics analyses also …
Our homology modeling, mutational analysis and molecular docking demonstrate that kinase 1 in obscurin harbors all key amino acids important …
Garlic for the common cold.
Lissiman E, Bhasale AL, Cohen M. Lissiman E, et al. Cochrane Database Syst Rev. 2014 Nov 11;2014(11):CD006206. doi: 10.1002/14651858.CD006206.pub4. Cochrane Database Syst Rev. 2014. PMID: 25386977 Free PMC article. Review.
Again, only one trial met the inclusion criteria.This trial randomly assigned 146 participants to either a garlic supplement (with 180 mg of allicin content) or a placebo (once daily)for 12 weeks. ...
Again, only one trial met the inclusion criteria.This trial randomly assigned 146 participants to either a garlic supplement (with 18 …
235 results